Nukes: Nucleoside Analog Reverse Transcriptase Inhibitors
To see a list of fact sheets in each category, click on the category name.
NOTE: You can see a full list of fact sheet topics on Fact Sheet 1000.
410. Nucleoside Analog Reverse Transcriptase Inhibitors in Development
A description of nucleoside analog drugs in development to treat HIV
[Revised May 6, 2011]
411. Zidovudine (Retrovir, AZT)
A description of the antiretroviral drug zidovudine (Retrovir®, AZT) including dosing, side effects, and a general discussion of who should take this drug.
[Revised February 27, 2011]
412. Zalcitabine (Hivid, ddC)
A description of the antiretroviral drug ddC (Hivid) which was discontinued from manufacture and sale in February 2006.
[Reviewed November 9, 2011]
413. Didanosine (Videx, ddI)
A description of the antiretroviral drug ddI (Videx®) including dosing, side effects, and a general discussion of who should take this drug.
[Revised January 10, 2012]
414. Stavudine (Zerit, d4T)
A description of the antiretroviral drug d4T (Zerit®) including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed December 17, 2011]
415. Lamivudine (Epivir)
A description of the antiretroviral drug 3TC (Epivir®) including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed November 9, 2011]
416. Abacavir (Ziagen)
A description of the antiretroviral drug Abacavir (Ziagen®) including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed November 6, 2011]
417. Combivir (zidovudine + lamivudine)
A description of the antiretroviral medication Combivir®, a combination of zidovudine and lamivudine, including dosing, side effects, and a general discussion of who should take this drug.
[Revised May 27, 2011]
418. Trizivir (zidovudine + lamivudine + abacavir)
A description of the antiretroviral medication Trizivir®, a combination of zidovudine, lamivudine, and abacavir, including dosing, side effects, and a general discussion of who should take this medication.
[Reviewed November 9, 2011]
419. Tenofovir (Viread)
A description of the antiretroviral drug tenofovir (Viread®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised January 21, 2012]
420. Emtricitabine (Emtriva)
A description of the antiretroviral drug (ARV) emtricitabine (Emtriva®), including dosing, side effects, and a general discussion of who should take this drug.
[Revised August 3, 2011]
421. Truvada (Tenofovir + Emtricitabine)
A description of the antiretroviral medication Truvada, a combination of tenofovir and emtricitabine, including dosing, side effects, and a general discussion of who should take this drug.
[Revised August 4, 2011]
422. Epzicom/Kivexa (abacavir + lamivudine)
A description of the antiretroviral medication Epzicom, a combination of abacavir and 3TC, including dosing, side effects, and a general discussion of who should take this drug.
[Reviewed November 9, 2011]
427. Hydroxyurea (Hydrea)
A description of the drug Hydroxyurea (Hydrea) including its use to fight HIV, dosing, and side effects
[Reviewed October 31, 2011]
Back to Fact Sheet Categories

The AIDS InfoNet is a project of the New Mexico AIDS Education and Training Center at the University of New Mexico Health Sciences Center.
webmaster@aidsinfonet.org

Partially funded by the National Library of Medicine




Print Version (Web)